MPR Weekly Dose 100 - Paxlovid EUA submission; Drugs linked to orthostatic hypotension; Besremi approved; Pill for remote endoscopy; Largest psilocybin trial to date episode artwork

EPISODE · Nov 19, 2021 · 13 MIN

MPR Weekly Dose 100 - Paxlovid EUA submission; Drugs linked to orthostatic hypotension; Besremi approved; Pill for remote endoscopy; Largest psilocybin trial to date

from MPR Weekly Dose

We made it to 100! This week Pfizer seeks Emergency Use Authorization for their COVID oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote endoscopy procedures; And the largest to date psilocybin trial shows promise in treatment-resistant depression. 

Episode metadata supplied by the publisher feed · Published Nov 19, 2021

Embed this episode

Ready to play

MPR Weekly Dose 100 - Paxlovid EUA submission; Drugs linked to orthostatic hypotension; Besremi approved; Pill for remote endoscopy; Largest psilocybin trial to date

0:00 13:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 13 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on November 19, 2021.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!